Accordingly, we cannot exclude the contribution of increased mitochondrial oxidative phosphorylation to TEFM-promoted HCC progression, although our data have demonstrated the involvement of ROS/ERK signaling activation in the oncogenic functions of TEFM in HCC. The gene discussed is TEFM; the disease is hepatocellular carcinoma.